Clinical Trials Logo
  1. Home
  2. Chronic Anal Fissure
  3. NCT00972907

An Open Label Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing in Human Subjects

Chronic Anal Fissure Clinical Trial

Official title:
An Open Label Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing in Human Subjects

Clinical Trial Summary

This is an open label study. The study will consist of 1 treatment group: coated Nifedipine suppository containing 12 mg of Nifedipine, administered BID to subjects with chronic anal fissure.

Clinical Trial Description

This is an open label study. The study will consist of 1 treatment group: coated Nifedipine suppository containing 12 mg of Nifedipine. Approximately 20 subjects will participate into this 8-week study. A screening visit will be used to determine subject suitability for inclusion in the trial. Within one week of the screening visit, subjects who meet all inclusion criteria and none of the exclusion criteria will receive Coated Nifedipine 12 mg Suppository X2 a day (BID) (24 mg/day total) for a period of 8 weeks. During this period, 4 study visits (at 0, 2, 5, and 8 weeks) will take place. Study medication will be administered BID (in the morning and in the evening). In addition to receiving study medication, subjects will be maintained on a standard treatment for Anal Fissure: sitz baths, high fiber diet. ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00972907
Study type Interventional
Source RDD Pharma Ltd
Contact
Status Completed
Phase Phase 1/Phase 2
Start date December 2009
Completion date February 2011
View Details
See also
  Status Clinical Trial Phase
Completed NCT03554421 - Percutaneous Tibial Nerve Stimulation - an Alternative Treatment Option for Chronic Therapy Resistant Anal Fissure N/A
Recruiting NCT05598164 - Botulinum Toxin Type A in the Treatment of Chronic Anal Fissure N/A
Terminated NCT02158013 - Treatment Of Chronic Anal Fissure N/A
Completed NCT01217515 - Diltiazem Hydrochloride Cream for Anal Fissure Phase 3
Recruiting NCT05117697 - Surgical Treatment of a Chronic Anal Fissure N/A
Completed NCT02527109 - The Effect of Intra-anal Nifedipine, Used As Add-on to Conservative Therapy, on Pain in Patients With Anal Fissure Phase 2/Phase 3
Recruiting NCT03920449 - Postero-lateral Internal Sphincterotomy vs Botulinum Toxin Injection in the Treatment of Chronic Anal Fissure N/A
Enrolling by invitation NCT04793347 - Effect of Shock Waves Therapy on Chronic Anal Fissure N/A
Completed NCT04166175 - High Dose Multiple Site Injection of Botox Versus Lateral Sphincterotomy in Chronic Analfissure N/A
Completed NCT02395809 - Transcutaneous Posterior Tibial Nerve Stimulation for Treatment of Chronic Anal Fissure N/A
Completed NCT01132391 - Perianal Versus Endoanal Application of Glyceryl Trinitrate 0.4% Ointment for Chronic Anal Fissure Phase 3
Completed NCT01500889 - Conventional Lateral Internal Sphincterotomy, V-Y Anoplasty and Tailored Lateral Internal Sphincterotomy With V-YF in Treatment of Chronic Anal Fissure(CAF) N/A
Completed NCT03872765 - Outcomes of the Use of CO2 (Carbon Dioxide) Laser in the Treatment of Chronic Anal Fissure N/A